ARN-509 is an antagonist of the androgen receptor (IC50 = 16 nM).{28061} It binds the receptor but does not cause nuclear localization or DNA binding.{28061} ARN-509 is orally bioavailable and, at 30 mg/kg/d, suppresses tumor growth in a mouse model of castration-resistant prostate cancer.{28061} This compound can be used to study androgen signaling in vitro and in vivo and has potential applications in certain types of cancer.{28062}
产品描述
An orally bioavailable antagonist of the androgen receptor (IC50 = 16 nM); at 30 mg/kg/d, suppresses tumor growth in a mouse model of castration-resistant prostate cancer